Centre for Neurosciences, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, USA.
Brain. 2010 Mar;133(Pt 3):690-700. doi: 10.1093/brain/awq017. Epub 2010 Mar 5.
Neurophysiological studies have provided evidence of primary motor cortex hyperexcitability in primary dystonia, but several functional imaging studies suggest otherwise. To address this issue, we measured sensorimotor activation at both the regional and network levels in carriers of the DYT1 dystonia mutation and in control subjects. We used (15)Oxygen-labelled water and positron emission tomography to scan nine manifesting DYT1 carriers, 10 non-manifesting DYT1 carriers and 12 age-matched controls while they performed a kinematically controlled motor task; they were also scanned in a non-motor audio-visual control condition. Within- and between-group contrasts were analysed with statistical parametric mapping. For network analysis, we first identified a normal motor-related activation pattern in a set of 39 motor and audio-visual scans acquired in an independent cohort of 18 healthy volunteer subjects. The expression of this pattern was prospectively quantified in the motor and control scans acquired in each of the gene carriers and controls. Network values for the three groups were compared with ANOVA and post hoc contrasts. Voxel-wise comparison of DYT1 carriers and controls revealed abnormally increased motor activation responses in the former group (P < 0.05, corrected; statistical parametric mapping), localized to the sensorimotor cortex, dorsal premotor cortex, supplementary motor area and the inferior parietal cortex. Network analysis of the normative derivation cohort revealed a significant normal motor-related activation pattern topography (P < 0.0001) characterized by covarying neural activity in the sensorimotor cortex, dorsal premotor cortex, supplementary motor area and cerebellum. In the study cohort, normal motor-related activation pattern expression measured during movement was abnormally elevated in the manifesting gene carriers (P < 0.001) but not in their non-manifesting counterparts. In contrast, in the non-motor control condition, abnormal increases in network activity were present in both groups of gene carriers (P < 0.001). In this condition, normal motor-related activation pattern expression in non-manifesting carriers was greater than in controls, but lower than in affected carriers. In the latter group, measures of normal motor-related activation pattern expression in the audio-visual condition correlated with independent dystonia clinical ratings (r = 0.70, P = 0.04). These findings confirm that overexcitability of the sensorimotor system is a robust feature of dystonia. The presence of elevated normal motor-related activation pattern expression in the non-motor condition suggests that abnormal integration of audio-visual input with sensorimotor network activity is an important trait feature of this disorder. Lastly, quantification of normal motor-related activation pattern expression in individual cases may have utility as an objective descriptor of therapeutic response in trials of new treatments for dystonia and related disorders.
神经生理学研究已经为原发性肌张力障碍中的初级运动皮层兴奋性过高提供了证据,但几项功能影像学研究表明并非如此。为了解决这个问题,我们在携带 DYT1 基因突变的患者和对照组中测量了区域和网络水平的感觉运动激活。我们使用(15)O 标记水和正电子发射断层扫描来扫描 9 名表现出 DYT1 携带者、10 名非表现出 DYT1 携带者和 12 名年龄匹配的对照者,同时他们执行了一个运动学控制的运动任务;他们还在非运动视听对照条件下进行了扫描。使用统计参数映射进行组内和组间对比分析。对于网络分析,我们首先在一组 39 个运动和视听扫描中确定了一个正常的运动相关激活模式,这些扫描是在一组 18 名健康志愿者的独立队列中获得的。然后,在每个基因携带者和对照组的运动和对照扫描中,前瞻性地定量表达了该模式。使用方差分析和事后对比比较了三组的网络值。对 DYT1 携带者和对照组的体素比较显示,前者的运动激活反应异常增加(P < 0.05,校正;统计参数映射),定位于感觉运动皮层、背侧运动前皮层、辅助运动区和下顶叶皮层。对正常来源队列的网络分析显示,存在显著的正常运动相关激活模式拓扑结构(P < 0.0001),其特征是感觉运动皮层、背侧运动前皮层、辅助运动区和小脑的神经活动共变。在研究队列中,在运动过程中测量的正常运动相关激活模式的表达在表现型基因携带者中异常升高(P < 0.001),但在非表现型携带者中则没有。相比之下,在非运动控制条件下,两组基因携带者的网络活动均异常增加(P < 0.001)。在这种情况下,非表现型携带者的正常运动相关激活模式表达高于对照组,但低于受影响的携带者。在后一组中,视听条件下正常运动相关激活模式表达的测量与独立的肌张力障碍临床评分相关(r = 0.70,P = 0.04)。这些发现证实了感觉运动系统的过度兴奋是肌张力障碍的一个强有力特征。在非运动条件下存在升高的正常运动相关激活模式表达表明,听觉视觉输入与感觉运动网络活动的异常整合是这种疾病的一个重要特征。最后,对个体病例中正常运动相关激活模式表达的定量可能作为新的肌张力障碍和相关疾病治疗试验中治疗反应的客观描述符具有一定的效用。